Where to begin?

You can read the full book or begin with the multimedia intro, published by Gnowbe. On their platform, you can connect to other readers/viewers through the Gnowbe community board. You can also reach out on LinkedIn to the authors via the links below, and you can discuss your own situation with the CJ2 digital twins below.

These books and articles were produced at S P Jain School of Global Management, which offers degree programs and executive education to craft global business leaders. The organization is known for its innovative approach to education and its leading-edge use of technology — the kind we need in healthcare and to develop the leaders we need for tomorrow’s healthcare.

The introduction also places the book within the High-Impact Business Innovation series, tying it to the original series idea of “Fusion” – crossing boundaries of industry, technology, nation, organizational silo, social class, and more to integrate disparate ideas, technologies, etc. into radical, high-impact, high-value innovation to the world (the way a great deal of energy is released in nuclear fusion). Radical healthcare advances from the book that spawned this series (Innovation Through Fusion), as well as those from the first book in the series (Famous Fusions), are introduced, as well as the digital twin companion and multimedia intro.

Chapter 2: AI and Capability Economics for Healthcare Investment, Policy, and Intervention Success: Sample Analysis of Alabama and Ethiopia Maternal Health by Dr. Ralph Welborn & Vince Kasten of Sunasi AI and Jacob Welborn, of Socios En Salud

Many (most) business executives and economic- and policy-makers assume outcomes are driven by sectors, institutions, technologies, or programs. Yet complex systems - from global supply chains to maternal health systems in fragile environments - do not ultimately succeed or fail at that level. They succeed or fail at the level of capabilities: the operational building blocks that determine whether systems can actually execute.

Capability economics offers a new lens for understanding these systems. By decomposing industries, organizations, and care conditions into networks of interdependent capabilities, it becomes possible to identify the critical few capabilities that drive disproportionate economic value and social impact. Advances in AI and graph-based analytics now allow these capability structures, and the chokepoints that constrain them and the leverage points to unlock them, to be mapped with unprecedented precision.

The implication is profound. Instead of hoping programs and investments can scale, leaders can design context-fit programs, focus investments on high-leverage capabilities, and sequence action to maximize impact. With precision.

Because in the end, outcomes follow capabilities.

Chapter 3: Last-Mile Humanitarian Medicine Across the Globe, by Sophie Delaunay, Doctors Without Borders (Médecins Sans Frontières - MSF) and Dr. John Boudreau, USC

This chapter describes both the necessity and the complexity of medical innovation in humanitarian settings, drawing on the experience of Medecins Sans Frontieres (MSF)’ s Transformational Investment Capacity (TIC). Through examples ranging from digital clinical decision support and AI-assisted diagnostics to large-scale learning platforms, a consistent lesson emerges: innovations succeed not through technological sophistication alone, but through their capacity to adapt to the operational, ethical and human realities of front-line care. Program-driven relevance, early and meaningful involvement of end users (beyond perfunctory advisory bodies), realistic assumptions about infrastructure, and sustained organizational support are decisive factors in determining whether an innovation can scale and become embedded in routine humanitarian operations or remain confined to pilot stages.

Chapter 4: Healthcare Innovation In-Context: Corporate R&D within Emerging Markets by Dr. Hemant Belsare, Becton Dickinson (BD)

Healthcare innovation is consistently portrayed as technology, investment, and scientific progress. However, in many developing economies the innovation process is not just about the technical sophistication of the innovation, but about how it fits into the healthcare context in the real world. The ability for solutions to be successfully implemented in systems with limited infrastructure, staffing, financial resources and fragmented care delivery is often difficult. This chapter presents an introduction to the idea of healthcare innovation in-context which focuses on the design of the technologies based around the realities of where they are going to be used. Based on a background of working with medical technology companies in various parts of the world, as well as doctoral studies in innovation management, the chapter explores how the four elements of contextual understanding, cross-functional cooperation, ecosystem partnerships and user-centric design can simultaneously make a difference in healthcare. It presents industry perspectives and case studies to make a case that emerging markets are not just markets where technologies developed in other regions are exported. They are increasingly becoming sources of innovation to drive the future of healthcare all over the world.

and fingerprint verification. If combined with new technology that detects breast cancer from fingerprints, going to the “store” for a prescription could save your life through both cancer screening and the medicine that brought you there in the first place. Ethical, legal, and logistical issues abound and haven’t been resolved -- yet. In emerging-economy contexts, for example, some technologies could be used by consumers who have access to mobile phones; some will require collaboration with trained community members or mobile healthcare workers; and some will need to be integrated into secure facilities and logistics chains. Nonetheless, this chapter shares a vision of how technology could enhance medical camps at The Tiger Center (TTC), a not-for-profit in central India that provides life-saving camps to people who have no healthcare access for 60 kilometers (37 miles).

Through OVO, a plastic-free menstrual-care line, and ScoutFast, an AI-driven funding-matching platform, their work argues that the barrier to better women's health was never a shortage of good ideas, but a shortage of the unglamorous scaffolding that lets good ideas survive contact with the real world. It is a story about trust, built one ordinary ritual at a time, and about what it takes to stop walking past a problem the world has learned to live with.  

Chapter 7: Human‑Centric Innovation for Affordable Healthcare - Integrating Science, Engineering, Technology, and People by Krish Krishnan, Jeiva International and ImmunoHeal Personalised Medicine

Healthcare innovation has drifted far from its central purpose: the patient. The funding structures, corporate incentives, and regulatory frameworks that govern how medical technology reaches market consistently prioritize patentability and clinical efficacy over what actually matters to sick people: quality of life, dignity, and the ability to live well alongside illness. Elegant, transformative innovations have been blocked or suppressed not because they failed patients, but because they failed to fit existing business models. AI offers real promise but the hype obscures what it can actually do: automate data and decision support, potentially freeing clinicians to restore the human relationship at the heart of care. Human-centered innovation is possible, and the companies that get it right show a consistent pattern: they co-design with patients, focus on clear gaps in standard care, seek long-term investment, and measure success by outcomes that matter to people, not just to payers.

Chapter 8: Playbook to Scale Healthcare in Africa with AI and Digital Health by Manny Samuel, Meridional Health

Africa’s healthcare system stands at a crossroads, where traditional physician-heavy models have left one-third of the population physically sidelined by a “distance barrier.” This chapter presents a visionary “Silicon-First” playbook, advocating for a transition from healthcare as a social burden to a digitally led economic engine. By leveraging 495 million mobile users as virtual clinical entry points, the proposed three-level triage model utilizes artificial intelligence (AI) as a digital gatekeeper and empowers nurse-led systems to bypass crumbling infrastructure. Through reflections on launching Voiladoc in Morocco and Madagascar, the author examines the “anatomy of systemic resistance,” including the “dumb pipe” mentality of telecommunications providers and insurers trapped in a “payer’s paradox.” Benchmarking successful Asian super-app blueprints, this chapter provides a roadmap to transform African wealth into health sovereignty. It concludes with a call for leaders to replace stagnant “staying afloat” mentalities with the exponential potential of AI-driven universal care.

judgment, local context, and ethical governance. The chapter ends with practical guidance for executives, investors, healthcare professionals, policymakers, and academics, urging them to invest in foundational capabilities, co-design with patients, and partner across silos, industries, and nations.